News
Stay updated with Hoba Therapeutics: Read our latest news, press releases, and find us at upcoming biotech events.
![A different approach to treating chronic pain and hearing loss](https://hobatherapeutics.com/wp-content/uploads/2024/02/Capture-decran-2024-02-26-a-14.52.13-e1708955664354.png)
Press releases
Hoba Therapeutics Appoints Jean Combalbert as Chairperson of the Board ofDirectors.
Copenhagen, March 1, 2024
Hoba Therapeutics, a Danish biotech company dedicated to developing novel therapeutic proteins for patients living ...
Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain
Copenhagen, December 11, 2023
Hoba Therapeutics, a Novo Holdings founded Danish biotech company dedicated to developing novel therapeutic ...
Eir Ventures invests in Hoba Therapeutics
Copenhagen, July 6, 2022
Hoba Therapeutics, a biotech company developing novel therapeutic proteins for pain, hearing loss, and sensory ...
Publications
Meteorin Alleviates Paclitaxel-Induced PeripheralNeuropathic Pain in Mice
Antihyperalgesic effects of Meteorin in the rat chronic constriction injury model: a replication study
Upcoming events
JPM Healthcare Conference 2025
January 13-16, 2025
San Francisco, CA, USA
Bio Partnering @ JPM